References
- WiechmannLKuererHMThe molecular journey from ductal carcinoma in situ to invasive breast cancerCancer2008112102130214218383519
- VaidyaYVaidyaPVaidyaTDuctal carcinoma in situ of the breastIndian J Surg201577214114626139969
- CowellCFWeigeltBSakrRAProgression from ductal carcinoma in situ to invasive breast cancer: revisitedMol Oncol20137585986923890733
- ChoudhuriTPalSAgwarwalMLDasTSaGCurcumin induces apoptosis in human breast cancer cells through p53-dependent Bax inductionFEBS Lett20025121–333434011852106
- MudduluruGGeorge-WilliamJNMuppalaSCurcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancerBiosci Rep201131318519720815812
- DeguchiACurcumin targets in inflammation and cancerEndocr Metab Immune Disord Drug Targets2015152889625772169
- CharpentierMSWhippleRAVitoloMICurcumin targets breast cancer stem–like cells with microtentacles that persist in mammospheres and promote reattachmentCancer Res20147441250126024371229
- MukherjeeSMazumdarMChakrabortySCurcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loopStem Cell Res Ther20145511625315241
- KunnumakkaraABAnandPAggarwalBBCurcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteinsCancer Lett2008269219922518479807
- MukhopadhyayACurcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylationOncogene200221578852886112483537
- VermaSPGoldinBRLinPSThe inhibition of the estrogenic effects of pesticides and environmental chemicals by curcumin and isoflavonoidsEnviron Health Perspect199810612807812
- SarkarFHLiYWangZPadhyeSLesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogsCurr Pharm Des201016161801181220345353
- ZhouHBeeversCSHuangSThe targets of curcuminCurr Drug Targets201112333234720955148
- PrasadCPRathGMathurSBhatnagarDRalhanRPotent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/β-catenin signalingChem Biol Interact2009181226327119573523
- ZhanYChenYLiuRZhangHZhangYPotentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signalingArch Pharm Res20143781086109524318305
- PrasadCPRathGMathurSBhatnagarDRalhanRExpression analysis of maspin in invasive ductal carcinoma of breast and modulation of its expression by curcumin in breast cancer cell linesChem Biol Interact2010183345546119944674
- ChenBZhangYWangYRaoJJiangXXuZCurcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expressionJ Steroid Biochem Mol Biol2014143111824486718
- KimBKimHS2JungEJCurcumin induces ER stress-mediated apoptosis through selective generation of reactive oxygen species in cervical cancer cellsMol Carcinog201655591892825980682
- GuanFDingYZhangYZhouYLiMWangCCurcumin suppresses proliferation and migration of MDA-MB-231 breast cancer cells through autophagy-dependent akt degradationPLoS One2016111e014655326752181
- KimSRParkHJBaeYHCurcumin down-regulates visfatin expression and inhibits breast cancer cell invasionEndocrinology2012153255456322186408
- KimHIHuangHCheepalaSHuangSChungJCurcumin inhibition of integrin (α6β4)-dependent breast cancer cell motility and invasionCancer Prev Res200815385391
- GuoJLiWShiHSynergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34aMol Cell Biochem2013382110311123771315
- SunKDuanXCaiHCurcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cellsClin Exp Med2016161374725596714
- PatelPBThakkarVRPatelJSCellular effect of curcumin and citral combination on breast cancer cells: induction of apoptosis and cell cycle arrestJ Breast Cancer201518322523426472972
- De GasperiMCavazosDdeGraffenriedLCurcumin modulates tamoxifen response in resistant breast cancer cellsCancer Res20096924 Suppl3098
- Somers-EdgarTJScandlynMJStuartECLe NedelecMJValentineSPRosengrenRJThe combination of epigallocatechin gallate and curcumin suppresses ERα-breast cancer cell growth in vitro and in vivoInt J Cancer200812291966197118098290
- SunALuYJHuHShojiMLiottaDCSnyderJPCurcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanismBioorg Med Chem Lett200919236627663119854644
- KakaralaMBrennerDEKorkayaHTargeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Res Treat2010122377778519898931
- Al-HujailyEMMohamedAGAl-SharifIPAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cellsBreast Cancer Res Treat201112819710720680677
- MohankumarKPajaniradjeSSridharanSMechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin – An in vitro and in silico approachChemico-Biol Interact20142105163
- WangSChenRZhongZEpigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cellsAm J Chin Med20144251279130025242081
- MohankumarKSridharanSPajaniradjeSBDMC-A an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway-a comparative study with curcuminBiomed Pharmacother20157417818626349982
- YallapuMMOthmanSFCurtisETCurcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applicationsInt J Nanomed2012717611779
- AnithaAMayaSDeepaNEfficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cellsCarbohydrate Polymers2011832452461
- KanaiMOtsukaYOtsukaKA phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patientsCancer Chemother Pharmacol20137161521153023543271
- ShehzadAWahidFLeeYSCurcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trialsArch Pharm20103439489499
- DhillonNAggarwalBBNewmanRAPhase II trial of curcumin in patients with advanced pancreatic cancerClin Cancer Res200814144491449918628464
- CarrollREBenyaRVTurgeonDKPhase II a clinical trial of curcumin for the prevention of colorectal neoplasiaCancer Prev Res201143354364
- SharmaRAEudenSAPlattonSLPhase I clinical trial of oral curcumin: biomarkers of systemic activity and complianceClin Cancer Res200410206847685415501961
- Nejati-KoshkiKAkbarzadehAPourhassan-MoghaddamMCurcumin inhibits leptin gene expression and secretion in breast cancer cells by estrogen receptorsCancer Cell Int2014146625866478
- LiontasAYegerHCurcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastomaAnticancer Res2004242B98799815161054
- MoosPJEdesKMullallyJEFitzpatrickFACurcumin impairs tumor suppressor p53 function in colon cancer cellsCarcinogenesis20042591611161715090465
- BerglindHPawitanYKatoSIshiokaCSoussiTAnalysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contaminationCancer Biol Ther20087569970818277095
- LimLYVidnovicNEllisenLWLeongCOMutant p53 mediates survival of breast cancer cellsBr J Cancer200910191606161219773755
- GartelALFelicianoCTynerTLA new method for determining the status of p53 in tumor cell lines of different originOncol Res2003136–1040540812725531
- ShaoZMShenZZLiuCHCurcumin exerts multiple suppressive effects on human breast carcinoma cellsInt J Cancer200298223424011857414
- SiebertAESanchezALDindaSMoudgilVKEffects of estrogen metabolite 2-methoxyestradiol on tumor suppressor protein p53 and proliferation of breast cancer cellsSyst Biol Reprod Med201157627928722077725
- HurdCKhattreeNAlbanPHormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell lineJ Biol Chem19952704828507285107499360
- DindaSSanchezAMoudgilVKEffects of LY117018 (a SERM analog of raloxifene) on tumor suppressor proteins and proliferation of breast cancer cellsHorm Mol Biol Clin Investig201021211217
- LaïosIJournéFNonclercqDRole of the proteasome in the regulation of estrogen receptor α turnover and function in MCF-7 breast carcinoma cellsJ Steroid Biochem Mol Biol200594434735915857754
- YehWLShiodaKCoserKRRivizzignoDMcSweeneyKRShiodaTFulvestrant-induced cell death and proteasomal degradation of estrogen receptor? Protein in MCF-7 cells require the CSK c-Src tyrosine kinasePLoS One201384e6088923593342
- JiZTangQZhangJYangYLiuYPanYOridonin-induced apoptosis in SW620 human colorectal adenocarcinoma cellsOncol Lett2011261303130722848306
- BergerEAMcClellanSAVistisenKSHazlettLDHIF-1α is essential for effective PMN bacterial killing, antimicrobial peptide production and apoptosis in Pseudomonas aeruginosa keratitisPLoS Pathog201397e100345723874197
- YedjouCGSaeedMAHossainMADorseyWYuHTchounwouPBBasic apoptotic and necrotic cell death in human liver carcinoma (HepG2) cells induced by synthetic azamacrocycleEnviron Toxicol201429660561122644747
- ChanLLLaiNWangESmithTYangXLinBA rapid detection method for apoptosis and necrosis measurement using the cellometer imaging cytometryApoptosis201116121295130321910006
- LiuQLooWTSzeSCTongYCurcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFκB, cyclinD and MMP-1 transcriptionPhytomedicine2009161091692219524420
- LiuDChenZThe effect of curcumin on breast cancer cellsJ Breast Cancer201316213313723843843